Literature DB >> 8157095

Loss of diurnal arrestin gene expression in rds mutant mouse retinas.

N Agarwal1, I Nir, D S Papermaster.   

Abstract

Despite the important advances in the molecular analysis of retinal degenerations, the causes of photoreceptor cell death in these conditions are unclear. To explore the metabolic impact of the rds mutation, we have continued our investigations on the expression of arrestin. Normal BALB/c mouse retinas have a diurnal variation in arrestin gene expression and protein biosynthesis, with low levels in dark-adapted and high levels in the light-adapted retinas. In contrast, arrestin is expressed in rds retinas at high levels throughout the diurnal cycle. A lack of a distinct diurnal cycle and continuously high expression of arrestin in rds retinas might be a reflection of metabolic derangements in these cells which are not an obvious consequence of the underlying molecular defect in the rds/peripherin gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157095     DOI: 10.1006/exer.1994.1189

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

1.  Circadian and noncircadian modulation of autophagy in photoreceptors and retinal pigment epithelium.

Authors:  Jingyu Yao; Lin Jia; Shameka J Shelby; Anna M Ganios; Kecia Feathers; Debra A Thompson; David N Zacks
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-29       Impact factor: 4.799

2.  Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells.

Authors:  Matthew J Loza; Susan Foster; Stephen P Peters; Raymond B Penn
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

Review 3.  Regulation of T cells in airway disease by beta-agonist.

Authors:  Matthew J Loza; Raymond B Penn
Journal:  Front Biosci (Schol Ed)       Date:  2010-06-01

4.  Rhythmic Regulation of Photoreceptor and RPE Genes Important for Vision and Genetically Associated With Severe Retinal Diseases.

Authors:  Patrick Vancura; Erika Csicsely; Annalisa Leiser; P Michael Iuvone; Rainer Spessert
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.